TW202237634A - 用於治療covid-19之dsg2組成物和方法 - Google Patents

用於治療covid-19之dsg2組成物和方法 Download PDF

Info

Publication number
TW202237634A
TW202237634A TW110146991A TW110146991A TW202237634A TW 202237634 A TW202237634 A TW 202237634A TW 110146991 A TW110146991 A TW 110146991A TW 110146991 A TW110146991 A TW 110146991A TW 202237634 A TW202237634 A TW 202237634A
Authority
TW
Taiwan
Prior art keywords
dsg2
ser
val
pro
thr
Prior art date
Application number
TW110146991A
Other languages
English (en)
Chinese (zh)
Inventor
施茵 符
萊恩 泰勒
Original Assignee
美商阿凡達醫療公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商阿凡達醫療公司 filed Critical 美商阿凡達醫療公司
Publication of TW202237634A publication Critical patent/TW202237634A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW110146991A 2020-12-15 2021-12-15 用於治療covid-19之dsg2組成物和方法 TW202237634A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063125583P 2020-12-15 2020-12-15
US63/125,583 2020-12-15
US202163274715P 2021-11-02 2021-11-02
US63/274,715 2021-11-02

Publications (1)

Publication Number Publication Date
TW202237634A true TW202237634A (zh) 2022-10-01

Family

ID=79425717

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110146991A TW202237634A (zh) 2020-12-15 2021-12-15 用於治療covid-19之dsg2組成物和方法

Country Status (9)

Country Link
EP (1) EP4263588A1 (enExample)
JP (1) JP2024500250A (enExample)
KR (1) KR20230120141A (enExample)
AU (1) AU2021400845A1 (enExample)
CA (1) CA3202364A1 (enExample)
IL (1) IL303444A (enExample)
MX (1) MX2023006704A (enExample)
TW (1) TW202237634A (enExample)
WO (1) WO2022132854A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2024005327A (es) * 2021-11-02 2024-05-21 Arvada Therapeutics Inc Composiciones y metodos de dsg2.
CN116458893A (zh) * 2023-04-19 2023-07-21 电子科技大学 一种covid-19后心肌缺血的早期筛查方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100316347B1 (ko) 1998-09-15 2002-08-27 한미약품(주) 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법
DE10057397A1 (de) 2000-11-18 2002-05-23 Hella Kg Hueck & Co Vorrichtung zur Ölstandsmessung
US20100303723A1 (en) * 2006-11-20 2010-12-02 Massachusetts Institute Of Technology Drug delivery systems using fc fragments
EP3568697B1 (en) * 2017-01-13 2022-06-29 The Hospital for Sick Children Method for diagnosis of arrhythmogenic right ventricular cardiomyopathy

Also Published As

Publication number Publication date
JP2024500250A (ja) 2024-01-05
AU2021400845A1 (en) 2023-07-13
CA3202364A1 (en) 2022-06-23
EP4263588A1 (en) 2023-10-25
WO2022132854A1 (en) 2022-06-23
MX2023006704A (es) 2023-06-20
KR20230120141A (ko) 2023-08-16
IL303444A (en) 2023-08-01

Similar Documents

Publication Publication Date Title
US5270199A (en) Human mannose-binding protein
US20180112193A1 (en) Csf1 therapeutics
JP4516718B2 (ja) 組換えエリスロポエチンと部分的に組合されたil−1インヒビターおよびtnfアンタゴニストの貧血治療用途
EP3065765B1 (en) Use of il-22 dimers in manufacture of medicaments for treating pancreatitis
JP2020511544A (ja) 関節リウマチを予防及び治療するための薬物の製造における選択性tnfr1拮抗ペプチドの使用
EP3442562B1 (en) An il-22 dimer for use in treating necrotizing enterocolitis
ES2293278T3 (es) Dimeros gp130 solubles pegilados utiles como un medicamento.
KR20230120141A (ko) Covid-19를 치료하기 위한 dsg2 조성물 및 방법
TW202143996A (zh) 使用可溶性cd24治療病毒性肺炎之方法
US20240279304A1 (en) Dsg2 compositions and methods
US20240043495A1 (en) Dsg2 compositions and methods for the treatment of covid-19
JP7649923B2 (ja) GPC3標的化抗体インターフェロンα融合タンパク質及びその使用
CN116648255A (zh) 用于治疗covid-19的dsg2组合物和方法
JP6416480B2 (ja) 関節リウマチまたはその関連疾患の予防または治療剤
US9617325B2 (en) Treatment of IgE-mediated disease
US20230167162A1 (en) Homing peptide-guided decorin conjugates for use in treating epidermolysis bullosa
KR20250134237A (ko) Dr5 도메인 변이체 및 이의 용도
HK40002973B (en) An il-22 dimer for use in treating necrotizing enterocolitis
HK40002973A (en) An il-22 dimer for use in treating necrotizing enterocolitis
HK1223556B (en) Use of il-22 dimers in manufacture of medicaments for treating pancreatitis